Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aetsoft (AET)

Aetsoft (AET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,637,976
  • Shares Outstanding, K 327,400
  • Annual Sales, $ 60,535 M
  • Annual Income, $ 1,904 M
  • 60-Month Beta 0.71
  • Price/Sales 1.15
  • Price/Cash Flow 17.10
  • Price/Book 3.75
Trade AET with:
  • Price/Earnings ttm 19.58
  • Earnings Per Share ttm 10.83
  • Most Recent Earnings $2.96 on 10/30/18
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 2.00 (0.94%)
  • Most Recent Dividend 0.500 on 10/23/18
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.81
  • Number of Estimates 9
  • High Estimate 1.92
  • Low Estimate 1.70
  • Prior Year 1.25
  • Growth Rate Est. (year over year) +44.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
194.39 +9.42%
on 10/29/18
213.36 -0.31%
on 11/28/18
+17.41 (+8.91%)
since 10/26/18
3-Month
194.27 +9.49%
on 10/26/18
213.36 -0.31%
on 11/28/18
+13.84 (+6.96%)
since 08/28/18
52-Week
166.88 +27.45%
on 04/02/18
213.36 -0.31%
on 11/28/18
+33.86 (+18.93%)
since 11/28/17

Most Recent Stories

More News
CVS Health tops forecasts, reserves billions for settlement

CVS Health booked a third-quarter loss of more than $3 billion after setting aside money for a potential opioid litigation settlement but still beat expectations and raised its 2022 forecast

$SPX : 5,251.31 (+0.05%)
$DOWI : 39,764.77 (+0.01%)
$IUXX : 18,256.89 (-0.13%)
AET : 212.70 (+0.33%)
CVS : 79.73 (+0.38%)
CVS Medicare Advantage business takes quality rating hit

CVS Health shares tumbled early Friday after the company said a big Medicare Advantage plan took a hit in government quality ratings about a week before a key enrollment window opens for the coverage.

AET : 212.70 (+0.33%)
CVS : 79.73 (+0.38%)
CVS to buy home health-care provider Signify for $8 billion

DALLAS (AP) — Drugstore operator CVS Health Corp. said Monday that it will buy home-health provider Signify Health for $8 billion.

AET : 212.70 (+0.33%)
CVS : 79.73 (+0.38%)
Growing prescriptions help push CVS past Q2 expectations

CVS Health thumped second-quarter expectations and hiked its full-year forecast as growing prescription claims and COVID-19 test kits sales countered a drop in vaccinations.

$SPX : 5,251.31 (+0.05%)
$DOWI : 39,764.77 (+0.01%)
$IUXX : 18,256.89 (-0.13%)
AET : 212.70 (+0.33%)
CVS : 79.73 (+0.38%)
PFE : 28.01 (+0.83%)
After another strong quarter, CVS raises outlook for 2022

COVID-19 vaccines and tests for the virus continue to boost CVS Health and the health care giant raised its annual forecast after yet another strong quarter.

$SPX : 5,251.31 (+0.05%)
$DOWI : 39,764.77 (+0.01%)
$IUXX : 18,256.89 (-0.13%)
CVS : 79.73 (+0.38%)
AET : 212.70 (+0.33%)
Walmart to end cigarette sales in some stores

NEW YORK (AP) — Walmart will no longer sell cigarettes in some of its stores though tobacco sales can be a significant revenue generator.

$SPX : 5,251.31 (+0.05%)
$DOWI : 39,764.77 (+0.01%)
$IUXX : 18,256.89 (-0.13%)
AET : 212.70 (+0.33%)
CVS : 79.73 (+0.38%)
TGT : 175.73 (+0.61%)
WMT : 60.57 (-0.25%)
3 million plaintiffs seek $1.2B from California health firm

SACRAMENTO, Calif. (AP) — A lawsuit over high health care bills filed on behalf of more than 3 million employers and people seeks as much as $1.2 billion from a large Northern California health system...

$SPX : 5,251.31 (+0.05%)
$DOWI : 39,764.77 (+0.01%)
$IUXX : 18,256.89 (-0.13%)
AET : 212.70 (+0.33%)
HNT : 67.19 (+3.67%)
COVID-19 vaccines, prescriptions fuel strong quarter at CVS

COVID-19 vaccines and the return of customers to stores helped push CVS Health well past fourth-quarter earnings expectations.

$SPX : 5,251.31 (+0.05%)
$DOWI : 39,764.77 (+0.01%)
$IUXX : 18,256.89 (-0.13%)
AET : 212.70 (+0.33%)
CVS : 79.73 (+0.38%)
Free cosmetic surgery offered in massive health fraud scheme

LOS ANGELES (AP) — In a surgical clinic in the California desert, what appeared on paperwork as “medically necessary” was more than a mirage. Explanations given to insurers were as phony as the breasts...

AET : 212.70 (+0.33%)
CI : 364.56 (+0.34%)
CVS Health to close hundreds of drugstores over next 3 years

CVS Health will close hundreds of drugstores over the next three years, as the health care giant adjusts to changing customer needs and converts to new store formats.

$SPX : 5,251.31 (+0.05%)
$DOWI : 39,764.77 (+0.01%)
$IUXX : 18,256.89 (-0.13%)
CVS : 79.73 (+0.38%)
AET : 212.70 (+0.33%)

Business Summary

Aetna Inc. is one of the nation's leading diversified health care benefits companies, serving the people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 214.19
1st Resistance Point 213.44
Last Price 212.70
1st Support Level 211.87
2nd Support Level 211.05
3rd Support Level N/A

See More

52-Week High 213.36
Last Price 212.70
Fibonacci 61.8% 195.61
Fibonacci 50% 190.12
Fibonacci 38.2% 184.64
52-Week Low 166.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar